Incidence
In this study, we identified 1106 cases as DAMAR from 102430 cases of inpatients, with the incidence of 1.08%. 125 of them with above 1000 IU/L CK values were identified as rhabdomyolysis with the incidence of 0.12%. The incidence of severe adverse reaction resembled with previous study reported 0.11% [14], but which only collected data with CK increased in 12 weeks in total, lacking large sample proof.